Skip to content Skip to footer

Therapeutic switching of a licensed oncology drug to target neuropathology in Parkinson's disease (2017-2019)

Experts

Associate Professor John O'Sullivan

Affiliate of Centre for Healthy Ageing Innovation
Centre for Healthy Ageing Innovation
Faculty of Health, Medicine and Behavioural Sciences
ATH - Associate Professor
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
John O'Sullivan
John O'Sullivan